Reuters: Health
Pfizer Inc is considering a collaboration with German drugmaker BioNTech SE to develop vaccines for the coronavirus using BioNTech's mRNA-based drug development platform, Pfizer's R&D head told Reuters on Thursday.
Subscribe UsPopular Posts
|
No comments:
Post a Comment